NRAD1 and thyroid cancer: In accordance with the abovementioned data, our experimental findings indicated that LINC00284 competitively bound to miR-30d-5p and inhibited its expression, suggesting the participation of the LINC00284-miR-30d-5p regulatory network in the development of thyroid cancer.